Cite
HARVARD Citation
Cremer, P. et al. (2021). Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. European Heart Journal Open. 1 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cremer, P. et al. (2021). Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. European Heart Journal Open. 1 (1), p. . [Online].